U.S. biotech company Genzyme Inc. (GENZ) rejected an $18.5 billion buyout offer from French drugmaker Sanofi-Aventis SA (SNY) on Monday, setting the stage for a protracted and potentially hostile takeover battle. – Reuters
U.S. biotech company Genzyme Inc. (GENZ) rejected an $18.5 billion buyout offer from French drugmaker Sanofi-Aventis SA (SNY) on Monday, setting the stage for a protracted and potentially hostile takeover battle. – Reuters
Copyright © 2024 Wall Street Pit | Contact Us | Advertise | Terms of Use | Privacy Policy
Leave a Reply